Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed2
Recruiting1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT02493530Phase 1Completed
TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
MyelofibrosisPolycythemia Vera
PrincipalinvestigatorStart date: 2015-07-01
NCT02658487Phase 2Completed
Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Multilineage Dysplasia+4 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sanjay Mohan, MD

Vanderbilt-Ingram Cancer Center

Very Similar
2 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Multilineage Dysplasia+4 more

Worked with same sponsors:

National Cancer Institute (NCI)Vanderbilt-Ingram Cancer Center
Collaborated on 1 trial
Similarity Score74%

Tapan M Kadia

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Secondary Acute Myeloid LeukemiaLeukemia, Myeloid, AcuteAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeSecondary Acute Myeloid Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrimary Myelofibrosis

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrimary Myelofibrosis
Similarity Score6%

Jorge E Cortes, MD

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrimary Myelofibrosis
Similarity Score6%

John Mascarenhas, MD

Icahn School of Medicine at Mount Sinai

Related
16 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia Vera

Worked with same sponsors:

Incyte CorporationNational Cancer Institute (NCI)
Similarity Score6%

Ronald Hoffman, MD

Icahn School of Medicine at Mount Sinai

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisPolycythemia Vera

Worked with same sponsors:

Incyte CorporationNational Cancer Institute (NCI)
Similarity Score6%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrimary Myelofibrosis

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia, Myeloid, Acute

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04061421Phase 1/2StudyChair

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

MDS/MPN
Recruiting
NCT02493530Phase 1PrincipalInvestigator

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

MyelofibrosisPolycythemia Vera
Completed
NCT02658487Phase 2PrincipalInvestigator

Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Multilineage Dysplasia+4 more
Completed

All 3 trials loaded